The influence of alendronate on bone formation after autogenous free bone grafting in rats

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 99, Issue 3, 2005, Pages 285-291

  Altundal, Hatice ^a   Gursoy, Bahar ^b  

^a YEDITEPE UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCITRIOL; CALCIUM; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BIOCHEMISTRY; BONE DEFECT; BONE GRAFT; BONE REMODELING; BONE TRANSPLANTATION; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; ENZYME BLOOD LEVEL; FEMUR; FOLLOW UP; HISTOPATHOLOGY; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOID; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; SURGICAL TECHNIQUE; VITAMIN BLOOD LEVEL;

EID: 13844317455     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2004.05.022     Document Type: Article

References (59)

1. D.A. Sass, A.R. Bowman, Z. Yuan, Y. Ma, W.S.S. Jee, and S. Epstein Alendronate prevents cyclosporin A induced osteopenia in the rat Bone 21 1997 65 70
2. H. Fleisch New bisphosphonates in osteoporosis Osteoporos Int 2 1993 15 22
3. J.P. Devogelaer, H. Broll, and R. Correa-Rotter Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis Bone 18 1996 141 150
4. S.A. Khan, S. Vasikaran, and E.V. McCloskey Alendronate in the treatment of Paget's disease of bone Bone 20 1997 263 271
5. M.R. McClung Bisphosphonates Endocrinol Metab Clin N Am 32 2003 253 271
6. E. Siris, R.S. Weinstein, and R. Altman Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone J Clin Endocrinol Metab 81 1996 961 967
7. M.H. Lafage, R. Balene, and M.A. Battle Comparison of alendronate and sodium fluoride effect on cancellous and cortical bone in minipigs J Clin Invest 95 1995 2127 2133
8. M.R. McClung Current bone mineral density data on bisphophonates in postmenopausal osteoporosis Bone 19 1996 195 198
9. J.A. Kanis, B.J. Gertz, F. Sibger, and S. Ortolani Rationale for the use of alendronate in osteoporosis Osteoporos Int 5 1995 1 13
10. J.R. Tucci, R.P. Tonino, R.D. Emkey, C.A. Peverly, U. Kher, and A.C. Santora Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis Am J Med 101 1996 488 501
11. L. Levin, E.C. Bryson, D. Caplan, and M. Trope Effect of topical alendronate on root resorption of dried replanted dog teeth Dent Traumatol 17 2001 120 126
12. D. Kaynak, R. Meffert, M. Günhan, Ö Günhan, and Ö Özkaya A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats J Periodontol 71 2000 790 796
13. M. Weinreb, H. Quartuccio, and J.G. Seedor Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys J Periodont Res 29 1994 35 40
14. U.M. El-Shinnawi, and S.I. El-Tantawy The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial) J Int Acad Periodontol 5 2003 5 10
15. I. Binderman, M. Adut, and A. Yaffe Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats J Periodontol 71 2000 1236 1240
16. A. Yaffe, M. Izitkovich, Y. Earon, I. Alt, R. Lilow, and I. Binderman Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats J Periodontol 68 1997 884 889
17. M.S. Reddy, T.W. Weatherford, C.A. Smith, B.D. West, M.K. Jeffcoat, and T.M. Jacks Alendronate treatment of naturally occurring periodontitis in beagle dogs J Periodontol 66 1995 211 217
18. K. Shoji, H. Horiuchi, and H. Shinoda Inhibitory effects of a biphosphonate (risedronate) on experimental periodontitis in rats J Periodont Res 30 1995 277 284
19. H. Warita, Y. Kirino, S. Kurihara, and K. Ohya Effects of local injection with bisphosphonate (HEBT) on experimental tooth movement J Jpn Orthod Soc 51 1992 292
20. L. Kayou, H. Sugiyama, S. Imoto, and K. Tanne Effects of bisphosphonate on the remodeling of rat sagittal suture after rapid expansion Angle Ortho 71 2001 265 273
21. K. Igarashi, H. Mitani, H. Adachi, and H. Shinoda Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movement in rats Am J Orthod Dentofacial Orthop 106 1994 279 289
22. K. Igarashi, H. Adachi, H. Mitani, and H. Shinoda Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats J Dent Res 75 1996 1644 1649
23. P. Aspenberg, and J. Astrand Bone allografts pretreated with a bisphosphonate are not resorbed Acta Orthop Scand 73 2002 20 23
24. H. Myoung, J.Y. Park, and P.H. Choung Effects of a bisphosphonate on the expression of bone specific genes after autogenous free bone grafting in rats J Periodontol Res 36 2001 244 251
25. H.C. Tenenbaum, A. Shelemay, B. Girard, R. Zohar, and P.C. Fritz Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses J Periodontol 73 2002 813 822
26. R. Schenk, P. Eggli, H. Fleisch, and S. Rossini Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat Calcif Tissue Int 38 1986 342 349
27. J.M. Owens, K. Fuller, and T.J. Chambers Osteoclast activation. Potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism J Cell Physiol 172 1997 79 86
28. G. Boivin, and P.J. Meunier Effects of bisphosphonates on matrix mineralization J Musculoskel Neuron Interact 2 2002 538 543
29. M. Sato, W. Grasser, and N. Endo Alendronate localization in rat bone and effects on osteoclast ultrastructure J Clin Invest 88 1991 2095 2105
30. J.A. Rodan, and H.A. Fleisch Bisphosphonate: mechanism of action J Clin Invest 97 1996 2692 2696
31. L.I. Plotkin, R.S. Weinstein, A.M. Parfitt, P.K. Roberson, S.C. Manolagas, and T. Bellido Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin J Clin Invest 104 1999 1363 1374
32. P. Masarachia, M. Weinreb, R. Balena, and G.A. Rodan Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones Bone 19 1996 281 290
33. E.R. Van Beek, C.W.G.M. Löwik, and S.E. Papapoulos Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice Bone 20 1997 335 340
34. E.R. Van Beek, C.W.G.M. Löwik, and S.E. Papalous Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors Bone 30 2002 64 70
35. M. Sahni, H.L. Guenther, H. Fleisch, P. Collin, and T.J. Martin Bisphosphonates act on rat bone resorption through the mediation of osteoblasts J Clin Invest 91 1993 2004 2011
36. M. Nishikawa, T. Akatsu, and Y. Katayama Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures Bone 18 1996 9 14
37. C. Vitte, H. Fleisch, and H.L. Guenther Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption Endocrinology 137 1996 2324 2333
38. H. Fleisch Mechanism of action of the bisphosphonates Medica 57 1997 65 75
39. H.C. Tenenbaum, M. Torontali, and B. Sukhu Effects of bisphosphonates and inorganic pyrophosphate on osteogenesis in vitro Bone 13 1992 249 255
40. A. Goziotis, B. Sukhu, M. Torontali, M. Dowhaniuk, and H.C. Tenenbaum Effects of bisphosphonates APD and HEBP on bone metabolism in vitro Bone 16 1995 317 327
41. P. D'Aoust, C.A.G. McCulloch, H.C. Tenenbaum, and P.C. Lekic Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria Cell Tissue Res 302 2000 353 363
42. P.M. Chavassieux, M.E. Arlot, C. Reda, L. Wei, A.J. Yates, and P.J. Meunier Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis J Clin Invest 100 1997 1475 1480
43. T. Storm, G. Thamsborg, T. Steinniche, H.K. Genant, and O.H. Sorensen Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis N Engl J Med 322 1990 1265 1271
44. D.W. Dempster Exploiting and bypassing the bone remodeling cycle to optimize treatment of osteoporosis J Bone Miner Res 12 1997 1152 1154
45. N. Giuliani, M. Pedrazzoni, G. Negri, G. Passeri, M. Impicciatore, and G. Girasole Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo Bone 22 1998 455 461
46. A. Yaffe, R. Kollerman, H. Bahar, and I. Binderman The influence of alendronate on bone formation and resorption in a rat ectopic bone development model J Periodontol 74 2003 44 50
47. E. Shane, V. Addesso, and P.B. Namerow Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation N Engl J Med 19 2004 751 754
48. D.E. Hughes, K.R. Wright, and H.L. Uy Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo J Bone Miner Res 10 1995 1478 1487
49. G.G. Renholtz, B. Getz, and L. Pederson Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts Cancer Res 60 2000 6001 6007
50. S.J. Meraw, and C.M. Reeve Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration J Periodontol 70 1999 1228 1233
51. C.G. Moreno, S. Serrano, and M. Nacher Effect of alendronate on cultured normal human osteoblasts Bone 22 1998 233 239
52. W. Jeal, L.B. Barradell, and D. Mctavish Alendronate: a review of its pharmacological properties and therapeutic efficacy in postmenopausal osteoporosis Drugs 53 1997 415 434
53. P. Bettica, M. Bevilacqua, T. Vago, M. Masino, and E. Cucinotta Short-term variations in bone remodeling biochemical markers: cyclical etidronate and alendronate effects compared J Clin Endocrinol Metab 82 1997 3034 3039
54. E.F. Eriksen, F. Melsen, E. Sod, I. Barton, and A. Chines Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis Bone 31 2002 620 625
55. P. Ravn, G. Neugebauer, and C. Christiansen Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis Bone 30 2002 320 324
56. P. Roschger, P. Fratzl, K. Klaushofer, and G. Rodan Mineralization of cancellous bone after alendronate and sodium fluoride treatment: A quantitative back scattered electron imaging study on minipig ribs Bone 20 1997 393 397
57. C.A. Frolik, H.U. Bryant, E.C. Black, D.E. Magee, and S. Chandrasekkar Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effect of raloxifene HCl, tamoxifen, estrogen, and alendronate Bone 18 1996 621 627
58. H. Altundal, and Ö Güvener The effect of alendronate on resorption of the alveolar bone following tooth extraction Int J Oral Maxillofac Surg 33 2004 286 293
59. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral and Maxillofac Surg 61 2003 1115 1118